ArticleTranslational cancer research2014
Identification of cancer mechanisms through computational systems modeling.
Article in Translational cancer research, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed, 11 citations in OpenAlex.
- Fuzzy optimization for identifying anti-cancer targets with few side effects in constraint-based models of head and neck cancer.Royal Society open science · 2022Article
- The Metabolic and Non-Metabolic Roles of UCK2 in Tumor Progression.Frontiers in oncology · 2022Review
- The impact of physiological metabolite levels on serine uptake, synthesis and utilization in cancer cells.Nature communications · 2021Article
- Prognosis Prediction for Colorectal Cancer Patients: A Risk Score Based on The Metabolic-Related Genes.International journal of medical sciences · 2021Article
- NMR and MS-based Stable Isotope-Resolved Metabolomics and Applications in Cancer Metabolism.Trends in analytical chemistry : TRAC · 2019Article
- Metabolomics-Based Biosignatures of Prostate Cancer in Patients Following Radiotherapy.Omics : a journal of integrative biology · 2019Article
- Control of Nucleotide Metabolism Enables Mutant p53's Oncogenic Gain-of-Function Activity.International journal of molecular sciences · 2017Review
- Inference of cancer mechanisms through computational systems analysis.Molecular bioSystems · 2017Article
- Regulation of mammalian nucleotide metabolism and biosynthesis.Nucleic acids research · 2015Review
- Strategies for Comparing Metabolic Profiles: Implications for the Inference of Biochemical Mechanisms from Metabolomics Data.IEEE/ACM transactions on computational biology and bioinformaticsArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 1 institution in 1 country.
Funding
Abstract
backgroundColorectal cancer is one of the most prevalent causes of cancer death. It has been studied extensively for a long time, and numerous genetic and epigenetic events have been associated with the disease. However, its molecular mechanisms are still unclear. High-throughput metabolomics data, combined with customized computational systems modeling, can assist our understanding of some of these mechanisms by revealing connections between alterations in enzymatic activities and their consequences for a person's metabolic profile. Of particular importance in this context is purine metabolism, as it provides the nucleotides needed for cell proliferation. METHODS AND
findingsWe employ a computational systems approach to infer molecular mechanisms associated with purine metabolism in colorectal carcinoma. The approach uses a dynamic model of purine metabolism as the simulation system and metabolomics data as input. The execution of large-scale Monte Carlo simulations and optimization with the model permits a step-wise reduction in possibly affected enzyme mechanisms, from which likely targets emerge.
conclusionsAccording to our results, some enzymes in the purine pathway system are very unlikely the targets of colorectal carcinoma. In fact, only three enzymatic steps emerge with statistical confidence as most likely being affected, namely: amidophosphoribosyltransferase (ATASE), 5'-nucleotidase (5NUC), and the xanthine oxidase/dehydrogenase (XD) reactions. The first of these enzymes catalyzes the first committed step of
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.